Manufacturing Excellence for Transformative Therapies

Your Lifelong Cell and Gene Therapy CDMO Partner

Bringing Your Cell and Gene Therapy to Life

Selecting a cell and gene therapy contract development and manufacturing organization (CDMO) partner is critical. At OmniaBio, we revolutionize cell and gene therapy manufacturing to enhance the affordability and accessibility of treatments. With decades of collective experience in both autologous and allogeneic cell therapies, we navigate the complexities of process development and GMP manufacturing to advance your program efficiently.

Our dedication to innovation and collaboration ensures that we are not just a CGT CDMO, but a true innovation partner in bringing your groundbreaking therapies to life for patients in need.

Early development to commercial capacity

Flexible, scalable technology solutions

AI-enabled development and GMP manufacturing

Seamless Transition from Early Development to Commercial Supply

Our expertise in advanced manufacturing services ensures the reliable execution needed to propel your program forward. Our comprehensive suite of services seamlessly merges technical proficiency in cell-based processes and gene delivery tools with cutting-edge advancements in process development and manufacturing. This integration provides holistic capabilities that span the entire product lifecycle – from preclinical development to large-scale commercial manufacturing.

With a variety of GMP suite options (Grade B or Grade C), we deliver GMP manufacturing of cell therapies that comply with U.S., Canadian, and European regulations. Trust us to guide your journey toward compliant, scalable, and cost-effective manufacturing.

Advancing Autologous Cell Therapies with Robust, Scalable Solutions

With over a decade of experience developing immune cell-based therapy processes, our team of technical experts specializes in developing and optimizing manufacturing platforms. We integrate closed-unit systems, AI models, and robotics to create robust, scalable, and efficient processes tailored to your needs.

Process Development

Process development and optimization expertise for enhanced robustness and reliable scale-up.

Analytical Development

Comprehensive analytical development services for tailored and established assays.

Autologous Manufacturing

Hamilton Intelligent Facility: AI and robotics integration for enhanced production rates and reduced costs.

Platform Expertise

Cutting-edge cell platforms for lentiviral vector-, immune cell- and iPSC-based therapies.

GMP Manufacturing

Resilient manufacturing for consistent quality, certified compliance, and minimal risks at every stage.

Commercial Manufacturing

Efficient scalability, timely QC release, and reliable delivery to support your commercial goals.

Personalized Client Services for Your Program's Success

Focused Manufacturing from Preclinical to Commercial Scale

As your reliable cell and gene therapy CDMO partner, we focus on reducing risk and amplifying assurance so that you can confidently move your program forward, knowing that it is in capable hands. Our teams ensure you receive the highest level of services, transparency, and collaboration. With CMC program requirements ranging in complexity and project type, our collaborative approach follows a standardized process customized for your needs, driving your success.

Seamless client onboarding with a dedicated project manager
Clear communication and documentation designed to meet your needs
Frequent project meetings and milestone tracking
Close to real-time data sharing

What’s New

OmniaBio opens Canada’s largest CGT manufacturing facility in Hamilton, Ontario, integrating AI, automation, and advanced technologies to enhance cell and gene therapy production. As a global CDMO, we partner with biotech innovators to deliver transformative therapies, driving affordability, accessibility, and advancements in regenerative medicine across North America and beyond.